Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Comparison of Low-Dose Naltrexone vs ARV Effectiveness in HIV+ Progression

NCT01174914 is registered in ClinicalTrials.gov with The Ojai Foundation as lead sponsor.

NCT NCT01174914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01174914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Comparison of Low-Dose Naltrexone vs ARV Effectiveness in HIV+ Progression
Lead sponsor
The Ojai Foundation
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
March 31, 2010
Enrollment
171 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv seropositivity